Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them
Retrieved from Malgave, A., Akbar, S., Tiwari, A., Hande, S., Joseph, A., & Malayandi, R
lower doses may yield less weight loss or slower progress
Legal Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice
J Gastroenterol Hepatol 33(1):232239